Next Article in Journal
In Memoriam: Professeur Daniel Wagner
Previous Article in Journal
Update on Arrhythmogenic Cardiomyopathies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cardiovascular Medicine
Volume 20
Issue 9
10.4414/cvm.2017.00510
cardiovascmed-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Long-Term Survival After Heart Transplantation

by
Mattia Cattaneo
1,*,
Luca Mazzucchelli
2,3,
Barbara Rüsi-Elsener
4,
Thomas Fehr
5,6 and
Augusto Gallino
1,6
1
Department of Cardiovascular Medicine, Ospedale Regionale di Bellinzona e Valli–San Giovanni, CH-6500 Bellinzona, Switzerland
2
Department of Pathology, Cantonal Pathology Institute, Locarno, Switzerland
3
University of Bern, Bern, Switzerland
4
HLA-Typisierungslabor, Universitätsspital Zürich, Zürich, Switzerland
5
Department of Nephrology and Physiology , HLA Typisierungslabor Universitätsspital Zürich, Zürich, Switzerland
6
University of Zürich, Zürich, Switzerland
*
Author to whom correspondence should be addressed.
Cardiovasc. Med. 2017, 20(9), 210; https://doi.org/10.4414/cvm.2017.00510
Submission received: 20 June 2017 / Revised: 20 July 2017 / Accepted: 20 August 2017 / Published: 20 September 2017
Versions Notes

Abstract

Orthotopic heart transplantation (HTX) represents the gold standard treatment for patients with advanced heart failure. The post-transplant survival of adult HTX recipients has consistently improved in past decades. As a result of increasing donor-recipient mismatch, as well as important technical and surgical advances, the attention of the medical community has shifted to ventricular assist devices (VADs) and to total artificial hearts. Here we present a patient who survived for 29 years after HTX at the age of 34 – a Caucasian male who manifested exceptionally few of the usual major post-HTX complications and was without typical cardiac allograft vasculopathy on autopsy. The scientific and medical community should not hesitate to persist with vigorous efforts to support research in transplantation and promote organ donation among the general population.
Keywords: heart transplantation; survival heart transplantation; survival

Share and Cite

MDPI and ACS Style

Cattaneo, M.; Mazzucchelli, L.; Rüsi-Elsener, B.; Fehr, T.; Gallino, A. Long-Term Survival After Heart Transplantation. Cardiovasc. Med. 2017, 20, 210. https://doi.org/10.4414/cvm.2017.00510

AMA Style

Cattaneo M, Mazzucchelli L, Rüsi-Elsener B, Fehr T, Gallino A. Long-Term Survival After Heart Transplantation. Cardiovascular Medicine. 2017; 20(9):210. https://doi.org/10.4414/cvm.2017.00510

Chicago/Turabian Style

Cattaneo, Mattia, Luca Mazzucchelli, Barbara Rüsi-Elsener, Thomas Fehr, and Augusto Gallino. 2017. "Long-Term Survival After Heart Transplantation" Cardiovascular Medicine 20, no. 9: 210. https://doi.org/10.4414/cvm.2017.00510

APA Style

Cattaneo, M., Mazzucchelli, L., Rüsi-Elsener, B., Fehr, T., & Gallino, A. (2017). Long-Term Survival After Heart Transplantation. Cardiovascular Medicine, 20(9), 210. https://doi.org/10.4414/cvm.2017.00510

Article Metrics

Back to TopTop